- Home
- AIMD
AIMD
Ainos Inc.
as 07-26-2024 4:00pm EST
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 5.3M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 339.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.66 - $5.10 | Next Earning Date: | 08-09-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Ainos Inc. News
AIMD Breaking Stock News: Dive into AIMD Ticker-Specific Updates for Smart Investing
ACCESSWIRE
4 days ago
Ainos Enrolls First Subject for Clinical Study of VELDONA-Based Animal FCGS Drug
ACCESSWIRE
a month ago
Ainos Unveils Critical Progress in Ainos Flora Clinical Trials and Next-Gen Plans Powered by NVIDIA CUDA
ACCESSWIRE
2 months ago
Ainos to Initiate Clinical Study of New Potential VELDONA-Based Animal Drug, Expanding VELDONA's Potential Market
ACCESSWIRE
2 months ago
Ainos Reports First Quarter 2024 Financial Results
ACCESSWIRE
3 months ago
Ainos Raises $9 Million in Growth Capital with Existing Shareholder
Simply Wall St.
5 months ago
Ainos Full Year 2023 Earnings: US$3.36 loss per share (vs US$5.14 loss in FY 2022)
ACCESSWIRE
5 months ago
Ainos Reports Full Year 2023 Financial Results
GlobeNewswire
6 months ago
Small-Cap Growth Virtual Investor Conference Presentations Now Available for Online Viewing
Compare AIMD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AIMD Ainos Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.